menu

Neuroplasticity: A Potential Target for the Treatment of Depression

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Neuroplasticity: A Potential Target for the Treatment of Depression

Details
Recommended

Overview

ReachMD Healthcare Image
RestartResume

Could neuroplastic changes in depression help to advance our treatment of depression in patients? Hear more.

  • Sponsored by

  • Overview

    The brain is constantly changing as a result of experience, stress, emotional processing, learning, and memory.1 And neuroplasticity adds another layer to these approaches by focusing on what’s actually changing in the brain.2 Tune in with Dr. Charles Turck as he speaks with Dr. Madhukar Trivedi, Founding Director of the Center for Depression Research and Clinical Care and Chief of the Division of Mood Disorders at the University of Texas Southwestern Medical Center in Dallas, Texas.

    1. Sanacora G, Treccani G, Popoli M. Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology. 2012;62(1):63-77.
    2. Mateos-Aparicio P, Rodriguez-Moreno A. The impact of studying brain plasticity. Front Cell Neurosci. 2019;13:66.

    August 2023  US.UNB.X.23.00081 

Schedule14 Jul 2024